| SBAC |
Report |
AFFO per share (Q2 2026) |
BEAT |
pred ~$3.02 vs. cons $2.96 |
MEDIUM |
| SBAC |
Report |
Site leasing revenue (Q2 2026) |
BEAT |
pred ~$665M vs. cons $657.96M |
MEDIUM |
| SBAC |
Report |
Total revenue (Q2 2026) |
IN-LINE |
pred ~$706M vs. cons $703.4M |
MEDIUM |
| SBAC |
Guide |
FY2026 AFFO per share guidance |
BETTER |
guide ~$12.05-$12.55 (mid ~$12.30) vs. cons ~$12.15 (FY2026) |
MEDIUM |
| SBAC |
Guide |
FY2026 Site leasing revenue guidance |
BETTER |
guide ~$2,665M-$2,695M (mid ~$2,680M) vs. cons ~$2,665M (FY2026) |
MEDIUM |
| SBAC |
Guide |
EchoStar + Sprint churn assumption (domestic, FY2026) |
UNCHANGED |
guide ~$112M combined churn vs. prior guide $112M (FY2026) |
MEDIUM |
| SBAC |
Guide |
Net debt/EBITDA leverage trajectory (post $3.5B unsecured notes deal) |
BETTER |
guide/actual ~6.4x vs. prior Q1 level 6.6x (Q2 2026, within 6.0x-7.0x target) |
LOW |
| SBAC |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.5% |
— |
LOW |
| SBAC |
Return |
5-day cumulative residual |
+1.0% (FADE) |
Beat-and-raise plus successful IG bond refinancing should drive an initial relief rally given the stock's ~20% pullback and wide gap to price targets, echoing constructive AMT/CCI reactions. But the FY26 guide raise looks modest relative to Q1's larger raise (implying H2 deceleration in domestic leasing as EchoStar/Sprint churn ($112M combined) and elevated international churn persist), leverage stays near the top of the 6.0x-7.0x target range even after the notes deal, and DISH bankruptcy/discovery proceedings remain an unresolved overhang alongside ongoing take-private speculation that has driven outsized, fundamentals-unrelated swings all summer — all of which should cap follow-through and pull the initial pop back in over the next few sessions. |
LOW |